ConductScience.org, home

Paper38457194

Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.

Bryson AL and 3 others. J Clin Microbiol, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales. Papers, record 38457194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38457194

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cefazolin as a predictor of urinary cephalosporin activity in indicated Enterobacterales.
PubMed
Journal
J Clin Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
1.58, provisional
iCite
Revised in PubMed
2026-06-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bryson ALAlexandra Lhttps://orcid.org/0000-0002-2957-7829
2Bhalodi AAmira
3Liesman RMRachael M
4Mathers AJAmy J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CefazolinMajor topic
Urinary Tract InfectionsMajor topic
Humans
Cephalosporins
Cephalothin
Anti-Bacterial Agents
Microbial Sensitivity Tests
Escherichia coli
Monobactams

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17872756Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7872756PubMed
24559812Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.Drugs1972https://conductscience.org/library/papers/4559812PubMed
32292526Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses.J Antimicrob Chemother1990https://conductscience.org/library/papers/2292526PubMed
47073267Pharmacokinetics of cefadroxil after oral administration in humans.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7073267PubMed
532659466A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of "Bad Bugs, Few Drugs".Int J Antimicrob Agents2020https://conductscience.org/library/papers/32659466PubMed
69114201Oral administration of antibiotics: a rational alternative to the parenteral route.Clin Infect Dis1997https://conductscience.org/library/papers/9114201PubMed
737358858Short-Course Therapy for Urinary Tract Infections in Children: The SCOUT Randomized Clinical Trial.JAMA Pediatr2023https://conductscience.org/library/papers/37358858PubMed
835861216Retrospective Comparison of Cefdinir, Cephalexin, and Sulfamethoxazole-Trimethoprim in the Treatment of Outpatient Pediatric Urinary Tract Infections.Clin Pediatr (Phila)2023https://conductscience.org/library/papers/35861216PubMed
93245701Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3245701PubMed
1017728468Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility.J Clin Microbiol2007https://conductscience.org/library/papers/17728468PubMed
117625793Suction-induced blister fluid penetration of cefdinir in healthy volunteers following ascending oral doses.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7625793PubMed
121761737Pharmacokinetic and tolerance studies of cefpodoxime after single- and multiple-dose oral administration of cefpodoxime proxetil.J Clin Pharmacol1991https://conductscience.org/library/papers/1761737PubMed
1310724022Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.Int J Antimicrob Agents2000https://conductscience.org/library/papers/10724022PubMed
1415728165Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.JAMA2005https://conductscience.org/library/papers/15728165PubMed
153777912Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3777912PubMed
1623680238Cephalothin susceptibility testing as class representative for oral cephalosporins: is it time to move on?Diagn Microbiol Infect Dis2013https://conductscience.org/library/papers/23680238PubMed
1733460959Surrogate testing of oral third-generation cephalosporin susceptibility to common uropathogens.Diagn Microbiol Infect Dis2021https://conductscience.org/library/papers/33460959PubMed
188833562Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.Ann Pharmacother1996https://conductscience.org/library/papers/8833562PubMed
1922318279Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.JAMA2012https://conductscience.org/library/papers/22318279PubMed
208507756Pharmacokinetics of new oral cephalosporins, including a new carbacephem.Clin Infect Dis1993https://conductscience.org/library/papers/8507756PubMed

See all 41 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
40304515Evaluation of MicroScan and VITEK 2 systems for susceptibility testing of Enterobacterales with updated breakpoints.J Clin Microbiol2025https://conductscience.org/library/papers/40304515PubMed
40047444Rapid detection of β-lactamase activity using the rapid Amp NP test.Microbiol Spectr2025https://conductscience.org/library/papers/40047444PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38457194

GET https://conductscience.org/api/papers/v1/38457194/references?page=2